Evie Koslosky
Stock Analyst at Goldman Sachs
(1.08)
# 3,763
Out of 5,182 analysts
7
Total ratings
40%
Success rate
-5.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Sell | $40 → $35 | $36.76 | -4.79% | 2 | Feb 13, 2026 | |
| MTD Mettler-Toledo International | Initiates: Neutral | $1,475 | $1,259.94 | +17.07% | 1 | Dec 9, 2025 | |
| RVTY Revvity | Initiates: Neutral | $105 | $88.94 | +18.06% | 1 | Dec 9, 2025 | |
| DHR Danaher | Initiates: Buy | $265 | $191.12 | +38.66% | 1 | Dec 9, 2025 | |
| A Agilent Technologies | Initiates: Buy | $170 | $115.48 | +47.21% | 1 | Dec 9, 2025 | |
| TMO Thermo Fisher Scientific | Initiates: Buy | $685 | $491.46 | +39.38% | 1 | Dec 9, 2025 |
Bruker
Feb 13, 2026
Maintains: Sell
Price Target: $40 → $35
Current: $36.76
Upside: -4.79%
Mettler-Toledo International
Dec 9, 2025
Initiates: Neutral
Price Target: $1,475
Current: $1,259.94
Upside: +17.07%
Revvity
Dec 9, 2025
Initiates: Neutral
Price Target: $105
Current: $88.94
Upside: +18.06%
Danaher
Dec 9, 2025
Initiates: Buy
Price Target: $265
Current: $191.12
Upside: +38.66%
Agilent Technologies
Dec 9, 2025
Initiates: Buy
Price Target: $170
Current: $115.48
Upside: +47.21%
Thermo Fisher Scientific
Dec 9, 2025
Initiates: Buy
Price Target: $685
Current: $491.46
Upside: +39.38%